Skip to main content

Table 3 Components of the free binding energetics between RVKDX, HVKXR, XLKDH, sotorasib, and adagrasib with KRASG12C expressed in kcal/mol with standard error of means. Computations were made with 200,000 MD trajectory snapshots

From: De Novo Rational design of peptide-based covalent inhibitors via mapping of complementary binding site residues – technical protocol and case study on KRASG12C and BTK481C

Energy Component (kcal/mol)

KRASG12C-RVKDX

KRASG12C-HVKXR

KRASG12C-XLKDH

KRASG12C- Sotorasib

KRASG12C- Adagrasib

∆EvdW

-49.67 ± 0.09

-39.07 ± 0.11

-42.08 ± 0.09

-61.65 ± 0.06

-76.29 ± 0.06

∆Eelec

-255.42 ± 0.62

-550.00 ± 0.85

-187.97 ± 0.57

-30.97 ± 0.09

-200.69 ± 0.25

∆GGB

264.39 ± 0.54

546.93 ± 0.75

187.04 ± 0.51

49.60 ± 0.09

214.01 ± 0.24

∆GSA

-8.15 ± 0.01

-6.79 ± 0.01

-5.66 ± 0.01

-7.61 ± 0.01

-8.77 ± 0.01

∆Ggas

-305.09 ± 0.62

-589.07 ± 0.81

-230.05 ± 0.58

-92.61 ± 0.10

-276.98 ± 0.26

∆Gsolv

256.24 ± 0.54

540.14 ± 0.75

181.38 ± 0.50

41.99 ± 0.09

205.24 ± 0.24

∆Gbind

-48.84 ± 0.13

-48.93 ± 0.14

-48.67 ± 0.11

-50.63 ± 0.07

-71.73 ± 0.08

  1. ∆Eelec (electrostatic energy), ∆EvdW (van der Waals energy), ∆GGB (polar solvation energy), ∆GSA (non-polar solvation energy), ∆Ggas (gas-phase energy), ∆Gsolv (Total solvation free energy of polar and non-polar states), and ∆Gbind (total free binding energy)